THIN FILM SOLAR FABRICATION PROCESS, DEPOSITION METHOD FOR TCO LAYER, AND SOLAR CELL PRECURSOR LAYER STACK

Methods for manufacturing a layer stack for a thin-film solar cell and layer stacks are provided. The layer stack includes a transparent substrate having a first refraction index, a transparent conductive oxide layer comprising ZnO, wherein the transparent conductive oxide layer is deposited over the substrate and has a second refraction index, and a further layer, which is deposited between the transparent conductive oxide layer and the substrate, wherein the layer has a third refraction index in a range from the first refraction index to the second refraction index, the layer comprises a metal, and wherein the layer composition has a metal content of 0.5 to 10 weight-%. 1. A layer stack for a thin-film solar cell , comprising:a transparent substrate having a first refraction index;a transparent conductive oxide layer comprising ZnO, the transparent conductive oxide layer is deposited over the substrate and has a second refraction index; anda further layer, which is deposited between the transparent conductive oxide layer and the substrate, wherein the layer has a third refraction index in a range from the first refraction index to the second refraction index, the layer comprises a metal, and wherein the layer composition has a metal content of 0.5 to 10 weight-%.2. The layer stack according to claim 1 , wherein the further layer is a SiON-containing layer.3. The layer stack according to claim 1 , wherein the further layer is a reactively sputtered layer.4. The layer stack according to claim 2 , wherein the further layer is a reactively sputtered layer.5. The layer stack according to claim 1 , wherein the metal in the further layer is selected from the group consisting of: Al claim 1 , Ti claim 1 , Zn and mixtures thereof.6. The layer stack according to claim 2 , wherein the Si content in the SiON-containing layer is about 30 weight-% or above.7. The layer stack according to claim 1 , wherein the transparent conductive oxide layer comprises at least 90 weight-% ZnO ...

IMPROVEMENT TO TRABECULECTOMY

The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of a plasmin or active derivative thereof in the form of topical eye drops alone, by anterior chamber injection alone, or by any combination of these. 1. A plasmin or an active truncated variant thereof for treating filtration failure after trabeculectomy surgery of an eye , or for preventing , reducing or retarding the occurrence of filtration failure after trabeculectomy surgery of an eye.2. The plasmin or variant thereof according to which is in a pharmaceutically acceptable formulation capable of being administered to an eye as topical eye drops.3. The plasmin or variant thereof according to which is in a pharmaceutically acceptable formulation capable of being administered by injection into the anterior chamber of an eye.4. The plasmin or variant thereof according to wherein said treating of filtration failure after trabeculectomy surgery of an eye claim 1 , or said preventing claim 1 , reducing or retarding of the occurrence of filtration failure after trabeculectomy surgery of an eye results from contacting said eye with an effective amount of topical eye drops comprising said plasmin or variant thereof.5. The plasmin or variant thereof according to wherein said treating of filtration failure after trabeculectomy surgery of an eye claim 1 , or said preventing claim 1 , reducing or retarding of the occurrence of filtration failure after trabeculectomy surgery of an eye results from introduction into the anterior chamber of an eye of an effective amount of said plasmin or variant thereof.6. The plasmin or variant thereof according to wherein said treating of filtration failure after trabeculectomy surgery of an eye claim 1 , or said preventing claim 1 , reducing or retarding of the ...

Cochlear Implant Power System and Methodology

A cochlear implant system has an implantable portion that includes a stimulator module for producing for the auditory system of a user an electrical stimulation signal representative of an acoustic signal. The implantable portion further includes a battery for supplying power to the stimulator module, a receiver module for receiving an electrical power signal across the skin of a user, and a recharge module that uses the electrical power signal to recharge the battery. The recharge module recharges the battery at less than the maximum recharge rate. 1. A cochlear implant system comprising: a power signal transmission module for transmitting an electrical power signal across the skin of a user; and', 'a battery for supplying power to the power signal transmission module; and, 'an external portion adapted for placement at a specific location on the external skin of a user, the external portion includingan implantable portion that receives the electrical power signal and produces for the auditory system of the user an electrical stimulation signal representative of an acoustic signal, wherein the implantable portion does not have a battery.2. The cochlear implant system according to claim 1 , wherein the battery is rechargeable.3. The cochlear implant system according to claim 1 , wherein the external portion is housed in a single enclosure claim 1 , the external portion including a first magnet claim 1 , the implantable portion including a second magnet claim 1 , the external portion adapted to be held in place on the user based on the magnetic forces between the first magnet and the second magnet.4. The cochlear implant system according to claim 1 , wherein the electrical power signal is free of modulated programming data.5. The cochlear implant system according to claim 1 , wherein the electrical power signal. includes low-rate modulated programming data.6. The cochlear implant system according to claim 1 , wherein the implantable portion includes:an electrode array ...

Sterilized Stethoscope Barrier Assembly

The present invention provides a sterilized barrier assembly for a stethoscope defined to have at least a stethoscope head. The barrier assembly includes two layers of material. A first layer of material has a first bottom side and an aseptic first top side. The first bottom side has an adhesive material permitting the first layer to be removably attached to the stethoscope head. The second layer of material has a second bottom side and a second top side. The second bottom side has a portion with adhesive such that the second bottom side is removably attached to the aseptic first top side, therefore the second layer of material can be removed from the first layer of material exposing the aseptic first top side to the atmosphere and for use with a patient. 1. A sterilized barrier assembly for a stethoscope defined to have at least a stethoscope head , the barrier assembly comprising:a first layer of material having a first bottom side and a first top side, the first bottom side having an adhesive material permitting the first layer to be removably attached to the stethoscope head, the first top side having a disinfectant and/or antiseptic agent; anda second layer of material having a second bottom side and a second top side, the second bottom side having a portion with adhesive such that the second bottom side is removably attached to the first top side,whereby when the second layer of material is removed from the first layer of material, the disinfectant and/or antiseptic agent on the first top side is exposed to the atmosphere.2. The sterilized barrier assembly of claim 1 , wherein the first and second layers of material are generally annular sheets of flexible material having a perimeter defined to cover a stethoscope cover.3. The sterilized barrier assembly of claim 1 , further comprising:at least one tab disposed on a terminal edge defined on each first and second layers of material.4. A method of sterilizing a stethoscope head defined on a stethoscope claim 1 , ...

TRABECULECTOMY OUTCOME

The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of an anti-PlGF antibody or fragment thereof. 1. A method of enhancing the success rate of trabeculectomy surgery of an eye , of treating filtration failure after trabeculectomy surgery of an eye , or of preventing , reducing or retarding the occurrence of filtration failure after trabeculectomy surgery of an eye , said method comprising the step of administering an anti-PlGF antibody or fragment thereof to said eye , thereby enhancing the success rate of trabeculectomy surgery of an eye , treating filtration failure after trabeculectomy surgery of an eye , or preventing , reducing or retarding the occurrence of filtration failure after trabeculectomy surgery.2. The method according to wherein at least a single dose of an effective amount said anti-PlGF antibody or fragment thereof is administered to said eye.3. The method according to further comprising administration of one or more of an agent for controlling the intra-ocular pressure claim 1 , an anti-inflammatory agent claim 1 , an antiviral agent claim 1 , an antibacterial agent claim 1 , an antiviral agent claim 1 , an anti-angiogenic agent claim 1 , an anti-mitotic agent claim 1 , an antihistamine claim 1 , an anesthetic claim 1 , an agent to induce mydriasis and an agent to induce cycloplegia.4. The method according to wherein said further contacting is occurring prior to claim 3 , concurrent with claim 3 , or after administering the anti-PlGF antibody or fragment thereof.5. The method according to wherein multiple doses of an effective amount of said anti-PlGF antibody or fragment thereof are administered to said eye.6. The method according to wherein said multiple doses are administered with at least 6-hour time intervals.7. The method ...

TURBO-MACHINERY STAGE FAMILIES TUNING/CALIBRATION SYSTEM AND METHOD

System and method for automatically determining a final set of tuning/calibration parameters for designing a new turbo-machinery. The method includes inputing an initial set of tuning/calibration parameters; calculating family turbo-machinery quantities based on the initial set of tuning/calibration parameters; comparing the calculated family turbo-machinery quantities with measured quantities and calculating a first error between the calculated family quantities and the measured quantities; calculating a second error between the initial set of tuning/calibration parameters and default values of the turbo-machine variables; forming a modified objective function that includes both the first and second errors; during an iterative process, varying the initial set of tuning/calibration parameters in such a way that the final set of tuning/calibration parameters is found; and storing in a database the final set of tuning/calibration parameters for the family. 1. A method for automatically determining a final set of tuning/calibration parameters for designing a new turbo-machinery , the method comprising:inputting an initial set of tuning/calibration parameters;calculating family turbo-machinery quantities based on the initial set of tuning/calibration parameters;comparing the calculated family turbo-machinery quantities with measured quantities and calculating a first error between the calculated family quantities and the measured quantities;calculating a second error between the initial set of tuning/calibration parameters and default values of the turbo-machine variables;forming a modified objective function that includes both the first and second errors;during an iterative process, varying the initial set of tuning/calibration parameters in such a way that the final set of tuning/calibration parameters is found and the final set of tuning/calibration parameters achieves (1) a best fit between the family of turbo-machinery quantities and the measured quantities, and (2 ...

Method for Treating Filtration Failure After Trabeculectomy Surgery

The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of a plasmin or active derivative thereof in the form of topical eye drops alone, by anterior chamber injection alone, or by any combination of these 1. A method for treating filtration failure after trabeculectomy surgery of an eye of a subject , the method comprising administering to the eye of the subject an effective amount of plasmin or an active truncated variant thereof.2. The method of claim 1 , wherein the plasmin or the active truncated variant thereof is in a pharmaceutically acceptable formulation administered to the eye as topical eye drops.3. The method of claim 1 , wherein the plasmin or the active truncated variant thereof is in a pharmaceutically acceptable formulation administered into the anterior chamber of the eye by injection.45.-. (canceled)6. The method of claim 1 , wherein the plasmin or the active truncated variant thereof is administered both by using topical eye drops comprising the plasmin or the active truncated variant thereof and by introduction of the plasmin or the active truncated variant thereof into the anterior chamber of the eye.7. The method of claim 1 , wherein the active truncated variant of plasmin lacks one or more kringle domains.8. The method of claim 1 , wherein the active truncated variant of plasmin is selected from the group consisting of midiplasmin claim 1 , miniplasmin claim 1 , microplasmin claim 1 , and deltaplasmin.9. The method of claim 1 , wherein the plasmin or the active truncated version thereof is in a pharmaceutically acceptable formulation further comprising an agent selected from the group consisting of an agent for controlling the intra-ocular pressure claim 1 , an anti-inflammatory agent claim 1 , an antiviral agent claim 1 , an ...

NOVEL INHIBITORS

The invention relates to a compound of formula (1): 12. The compound according to claim 1 , which is a compound selected from:5-[3-({4′-fluoro-[1,1′-biphenyl]-2-yl}amino)propyl]-1,3,4-thiadiazol-2-amine;5-{[2-({4′-fluoro-[1,1′-biphenyl]-2-yl}amino)ethyl]sulfanyl}-1,3,4-thiadiazol-2-amine;5-{[2-({3′,4′-dimethoxy-[1,1′-biphenyl]-2-yl}amino)ethyl]sulfanyl}-1,3,4-thiadiazol-2-amine;5-[4-({4′-fluoro-[1,1′-biphenyl]-2-yl}amino)phenyl]-1,3,4-thiadiazol-2-amine;5-(4-{[2-(3,4-dimethoxyphenyl)phenyl]amino}phenyl)-1,3,4-thiadiazol-2-amine;5-(4-{[2-(4-methoxyphenyl)phenyl]amino}phenyl)-1,3,4-thiadiazol-2-amine;N-[4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl]-3-(4-methoxyphenyl)pyridin-2-amine;N-[4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl]-3-(4-methoxyphenyl)pyridin-4-amine;N-[4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl]-3-(3,4-dimethoxyphenyl)pyridin-4-amine;N-[4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl]-3-(4-fluorophenyl)pyridin-2-amine;N-[4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl]-3-(4-fluorophenyl)pyrazin-2-amine;5-(4-{[2-(4-phenoxyphenyl)phenyl]amino}phenyl)-1,3,4-thiadiazol-2-amine;5-(4-{[2-(4-propoxyphenyl)phenyl]amino}phenyl)-1,3,4-thiadiazol-2-amine;5-[4-({2-[4-(propan-2-yloxy)phenyl]phenyl}amino)phenyl]-1,3,4-thiadiazol-2-amine;N-[3-(5-amino-1,3,4-thiadiazol-2-yl)propyl]-4-fluorobenzene-1-sulfonamide;N-{2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]ethyl}-4-fluorobenzene-1-sulfonamide;5-(3-{[(4-fluorophenyl)(methyl)oxo-λω-sulfanylidene]amino}propyl)-1,3,4-thiadiazol-2-amine;N-[4-(2-amino-1,3-thiazol-5-yl)phenyl]-4-fluorobenzene-1-sulfonamide;N-[4-(2-amino-1,3-thiazol-5-yl)phenyl]-3,4-dimethoxybenzene-1-sulfonamide;5-(1-{4′-fluoro-[1,1′-biphenyl]-2-yl}piperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-[1-(4-fluorobenzenesulfonyl)piperdino-4-yl]-1,3-thiazol-2-amine;5-[1-(4-fluorobenzenesulfonyl)piperidin-4-yl]-1,3,4-thiadiazol-2-amine;or a pharmaceutically acceptable salt or solvate thereof, including all tautomers and stereoisomers.13. A pharmaceutical composition comprising a compound according ...

Preview for a print job

A computing system can include a preview module and a display interface. In some examples, the preview module can obtain adjustment values for adjusting an operation for a printer to achieve or form an output of the printer with a set of attributes included in a print job. Additionally, the preview module can generate a preview of the output, based on the adjustment values, the set of attributes and a set of configuration parameters of the display component. In such examples, the preview can be based on the adjustment values, the set of attributes and a set of configuration parameters of the display component. In some examples, the preview module can communicate the preview of the output to a display component using the display interface.

Relating print coverage matrices to object property matrice

In an example, a method includes receiving, at a processor, a first matrix comprising a set of print coverage vectors, each print coverage vector specifying print materials for object generation using additive manufacturing and a second matrix comprising a corresponding set of properties for objects generated using the print coverage vectors. The method may further include determining, by the processor, a solution to an objective function relating the first and second matrices.

Phytophthora resistant plants belonging to the solanaceae family

The present invention relates to a plant belonging to the Solanaceae family wherein said plant comprises a genetic trait providing Phytophthora resistance and wherein said resistance trait is encoded by a combination of at least two genes having a reduced expression, or transcription, of said genes or a reduced activity of proteins encoded by said genes as compared to said plant belonging to Solanaceae family being susceptible to Phytophthora . The present invention especially relates to plants belonging to the Solanaceae family selected from the group consisting of sweet pepper ( Capsicum annuum ), Capsicum spp., potato ( Solanum tuberosum ), petunia, tomato ( Solanum lycopersicum ), Nicotinia benthamiana , and tabacco ( Nicotinia tabacum ), and the present Phytophthora resistance is especially a resistance to a plant pathogen selected from the group consisting of Phytophthora spp., Phytophthora capsici, Phytophthora infestans , and Phytophthora nicotinae.

NEW DIARYLAMINES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE

Cells and processes for the production of acetone

Gegenstand der Erfindung sind Zellen und ein Verfahren zur Aceton-Produktion. The invention relates to cells and a method for acetone production.

Dishwasher etc. with storage container - for softened water emptied into work container, equipped with separator part containers

Microbiological production of 3-hydroxyisobutyric acid

Process for the preparation of alkyl (meth) acrylates

Die vorliegende Erfindung betrifft Verfahren zur Herstellung von Alkyl(meth)acrylaten, umfassend die Schritte DOLLAR A Umesterung eines alpha-Hydroxycarbonsäurealkylesters mit (Meth)acrylsäure, wobei Alkyl(meth)acrylate sowie alpha-Hydroxycarbonsäure erhalten werden, DOLLAR A und DOLLAR A Dehydratisierung der alpha-Hydroxycarbonsäure, wobei (Meth)acrylsäure erhalten wird. The present invention relates to processes for the preparation of alkyl (meth) acrylates, comprising the steps DOLLAR A transesterification of an alpha-hydroxycarboxylic acid alkyl ester with (meth) acrylic acid to give alkyl (meth) acrylates and alpha-hydroxycarboxylic acid, DOLLAR A and DOLLAR A dehydration of alpha-hydroxycarboxylic acid to give (meth) acrylic acid.

Process for transesterification

Die vorliegende Erfindung betrifft Verfahren zur Umesterung, umfassend die Schritte DOLLAR A A) Mischen einer organischen Säure a) mit einem Ester b) und DOLLAR A B) Übertragen des Alkoholrestes des Esters b) auf die Säure a), wobei der Ester der Säure a) und die Säure des Esters b) erhalten werden, wobei Schritt B) in einer Destille durchgeführt wird. The present invention relates to processes for transesterification, comprising the steps DOLLAR AA) mixing an organic acid a) with an ester b) and DOLLAR AB) transferring the alcohol residue of the ester b) to the acid a), wherein the ester of the acid a) and the acid of the ester b) are obtained, wherein step B) is carried out in a still.

IMPROVED LIQUID CRYSTALINE DYE COPOLYMERS

Opposing paired cylinders of iC engine - are connected by common piston rod, with independent connecting rods providing swivel connection to crankshaft

The internal combustion engine has counterposed cylinders with a crankshaft located between them. The pistons of the opposing cylinders (13, 14 & 15, 16), which are arranged in pairs, are connected to each other by common connecting rod (19, 22), and further connecting rods (23, 24) swivel connect them to the crankshaft. A further arrangement is for a common connecting rod to connect the piston pair to the crankshaft, and for the piston rods (19, 22) of each pair to be connected to rod frame, which is H-shaped, via a traverse, with the head of the common connecting rod to the crankshaft to be swivelable connected to this traverse.

System and method for effectively rendering high dynamic range images

A system and method for rendering high dynamic range images includes a rendering manager that divides an original luminance image into a plurality of original subband images. The rendering manager converts the original subband images into original contrast images which are converted into original perceived contrast images. The rendering manager performs a compression procedure upon the original perceived contrast images to produce compressed perceived contrast images. The rendering manager converts the compressed perceived contrast images into compressed contrast images which are converted into compressed subband images. The rendering manager performs a subband combination procedure for combining the compressed subband images together with a lowest-frequency subband image to generate a rendered luminance image. The rendering manager may combines the rendered luminance image with corresponding chrominance information to generate a rendered composite image.

IMPLANTABLE HORN PROTESTS

Implant sensor and control

Combination therapy for hyperproliferative diseases

This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of adminestering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine, hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan and CamptosarÚ, an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypersensitive agent.

NEW N-SULFENYL CARBAMATES THEIR PREPARATION PROCESS AND THEIR APPLICATION AS INSECTICIDES AND ACARICIDES

BONE PLATE IN Y FOR THE DISTAL PART OF THE HUMERUS.

Plaque osseuse en Y pour la partie distale de l'humérus, comprenant une partie principale (1) qui est destinée à être appliquée dorsalement sur le diaphyse et à laquelle font suite deux parties (4, 5) en fourche destinées à être appliquées en direction des condyles du coude. La partie externe (4) de la fourche présente une courbure convexe et la partie interne (5) de la fourche ou la région de transition (3) entre la partie principale (1) et la partie interne (5) de la fourche présente une courbure concave. Y-shaped bone plate for the distal part of the humerus, comprising a main part (1) which is intended to be applied dorsally to the shaft and to which follow two forked parts (4, 5) intended to be applied in direction of the elbow condyles. The outer part (4) of the fork has a convex curvature and the inner part (5) of the fork or the transition region (3) between the main part (1) and the inner part (5) of the fork has a concave curvature.

Structure, method of use, and method of manufacture of an implanted hearing prosthesis

A hearing prosthesis is provided for implantation into a subject that includes a flexible electrode carrier for insertion along the length of the cochlea, the electrode carrier bearing along its length, a number of contact members that are superficially placed in pairs, each member of each pairs being diametrically opposite the other. A method of manufacture of the prosthesis is further provided.

Fabric softener concentrate

Wäscheweichspülmittelkonzentrate bestehend aus a) 30 bis 70 Gew.-% eines kationischen Weichmachers, b) 5 bis 50 Gew.-% eines nichtionischen Weichmachers, c) 5 bis 20 Gew.-% eines nichtionischen Dispergiermittels, d) 5 bis 30 Gew.-% eines C1-C3-Alkanols, e) 5 bis 30 Gew.-% eines flüssigen Glykols, Polyglykols oder deren Alkyläther und f) Wasser und gegebenenfalls Parfüm und Farbstoffen in Mengen entsprechend dem Ausgleich zu 100 Gew.-%. Laundry softener concentrates consisting of a) 30 to 70% by weight of a cationic softener, b) 5 to 50% by weight of a nonionic softener, c) 5 to 20% by weight of a nonionic dispersant, d) 5 to 30% by weight % of a C1-C3 alkanol, e) 5 to 30% by weight of a liquid glycol, polyglycol or their alkyl ether and f) water and optionally perfume and dyes in amounts corresponding to the balance to 100% by weight.

Powdery mildew resistance providing genes in cucumis sativus

The present invention relates to powdery mildew resistance providing genes of the Cucumis family, and especially Cucumis sativus, wherein said resistance is provided by impairment of the present genes. Further, the present invention relates plants comprising the present impaired resistance conferring genes and seeds, embryos or other propagation material thereof. Especially, the present invention relates to powdery mildew resistance conferring genes, wherein the amino acid sequence encoded by said resistance conferring gene is selected from the group consisting of SEQ ID No. 2, SEQ ID No. 4, SEQ ID No. 6, SEQ ID No. 8, SEQ ID No. 10, SEQ ID No. 12, SEQ ID No. 14, SEQ ID No. 16, SEQ ID No. 18, SEQ ID No. 20 and SEQ ID No. 22, and amino acid sequences with more than 70% identity, preferably more than 80% identity, more preferably more than 90% identity, and most preferably more than 95% identity.

Process for preparing alkyl (meth)acrylates

3 8 7,00@C 2 32-:@ @QLOSP( ABSTRACT PROCESS FOR PREPARING ALKYL (MOTH)ACRYLATES 7HE PRESENT INVENTION RELATES TO PROCESSES FOR PREPARING ALKYL (METH)ACRYLATES, COMPRISING THE STEPS OF 5 TRANSESTERIFYING AN ALKYL A-HYDROXYCARBOXYLATE WITH (METH)ACRYLIC ACID TO OBTAIN ALKYL (METH)ACRYLATES AND A-HYDROXYCARBOXYLIC ACID, AND DEHYDRATING THE A-HYDROXYCARBOXYLIC ACID TO OBTAIN (METH)ACRYLIC ACID.

BETA-AZOLYL-ALDOXIME CARBAMATES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS INSECTICIDES, ACARICIDES AND NEMATICIDES

SOFTENER COMPOSITION FOR TEXTILE MATERIALS

Trifluoromethylbenzylic esters, their intermediates, process for their preparation and their use as insecticides

Determining property mapping resources with property constraints in an additive manufacturing

In an example, a method includes receiving, at a processor, a plurality of property parameter sets representing attainable property combinations in additive manufacturing and being associated with print material description. A constraint of a first property of the property parameter sets may also be received and a hull of a property mapping resource for use in determining additive manufacturing instructions for generating an object in which the first property meets the received constraint may be determined.

Technique, for controlling flow of reactive gas in plasma vacuum deposition process, involves using optical spectroscopy to measure the particle stream intensities in the coating material and the reactive gas

To control the flow of a reactive gas, in a reactive plasma vacuum deposition process, a control value is set by a plasma from the vacuum chamber (1) in a monitoring stretch. A measurement unit (9) uses optical spectroscopy, and the values are processed at an electronic control unit (13) to set the volume of delivered gas according to any deviations from the required control settings. The control value is computed from a measurement of the intensity of a spectral line in the particle stream of the coating material (3), and the measured intensity of a particle stream of the reactive gas (6). The measurement unit has an acoustic/optical spectrometer (12) with a control input and a regulating output linked to it.

FLUORALKENYL-SUBSTITUTED CYCLOPROPANCARBONIC ACID ESTERS AND THEIR USE AS INSECTICIDES

Implantable fluid delivery apparatuses and implantable electrode

A cochlear implant system is described. An implantable housing includes an electronics module containing circuitry for developing an electrical stimulation signal for the inner ear, and a fluid channel port for receiving therapeutic fluid for the inner ear. An electrode array includes multiple electrode contacts in electrical communication with the electronics module for stimulating neural tissue of the inner ear with the electrical stimulation signal, and a fluid delivery channel for delivering the therapeutic fluid from the fluid channel port to the inner ear.

2-CYCLOPROPYL-PYRIMIDINE (4) YL- (THIONO) (THIOL) -PHOSPHOR- (PHOSPHON) -ACIDESTERS OR. -ESTERAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL

SUBSTITUTED CYCLOHEXANE-2,6-Dione-1CARBONIC ANILIDES AND THIOANILIDES, METHOD FOR THEIR MANUFACTURING AND USE AS INSECTICIDES, ACARICIDES AND FUNGICIDES

Composition comprising a pulmonary surfactant and a tnf-derived peptide

The invention relates to the combination of a pulmonary surfactant and a TNF-derived peptide and its use for the treatment of respiratory disease.

System and method for estimating image sharpness

A method for determining image sharpness estimation of an image. Image data for at least one column of pixels and at least one row of pixels of the image is sampled. A first filter is applied on sequential differences of sampled image data resulting in a first filtered sequence of first filtered values. A second filter is applied on the sequential differences resulting in a second filtered sequence of second filtered values. A feature set of pixels of the image is selected. Image sharpness estimation is determined based on the first filtered values and the second filtered values of the feature set of pixels.

Quaternary alkylamino-di-alkylcarbonic acid-di-esters, process for their preparation and their use

Combination therapy for hyperproliferative diseases

This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of adminestering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine, hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan and CamptosarÚ, an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypersensitive agent.

Pad, pad holder, assembly, and method for producing a beverage

Pad for producing a beverage, provided with a first permeable layer and a second permeable layer opposite to the first permeable layer. The pad is further provided with a filling arranged in between the first and second permeable layer. The pad is arranged for receiving pressurized water through the first permeable layer, for dissolving, dispersing, and/or extracting at least part of the filling in the received pressurized water. The pad is arranged for releasing through the second permeable layer the water with the at least part of the filling dissolved, dispersed, and/or extracted therein. The first permeable layer has a plurality of apertures for receiving the pressurized water. The apertures have a size dimensioned for establishing swirling motion of the water inside the filling.

Electric component e.g. organic LED, has buffer layer and short-circuit suppression layer arranged between function layer and anode, where short-circuit suppression layer has uniform thickness in its layer plane

The component has an organic LED (OLED) layer stack (3) arranged between an anode (1) and an aluminum cathode (2) and comprising a function layer e.g. emission layer or absorption layer, made of an organic material. An electrically conductive buffer layer (4) and a short-circuit suppression layer (5) are arranged between the function layer and anode, where electric conductivity of the buffer layer is higher than that of the short-circuit suppression layer. The short-circuit suppression layer has uniform thickness (d) in its layer plane independent of topology of the adjacent layers. An independent claim is also included for a method for manufacturing an electric component.

Providing a mapping data structure for use in generating a proof

To generate a proof of a printable item, a data structure is provided that maps a set of spot colors into a respective set of color values based on measurement data provided by a measurement device of colors printed by a printing system from the spot colors.

Method of derivatising an analyte for subsequent detection through a nucleic acid based sensor

A method of derivatising an analyte for subsequent detection through a nucleic acid based sensor and a sensor based thereon.

NEW N-ARYL-N'-ALKYL-S-ALKYL-ISOTHIOHARN SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN AGENT FOR CONTROLLING ANIMAL AND VEGETABLE PEST

Composition comprising a pulmonary surfactant and a TNF-derived peptide

2-PHENYL-ALKEN-1-YL-CYCLOPROPANE-CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INSECTICIDES AND ACARICIDES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION

1-Aroyl-2-phenylamino-2-imidazolines, their preparation and their pharmaceutical compositions

Die Erfindung betrifft 1-Aroyl-2-phenylamino-2-imidazoline der allgemeinen Formel <IMAGE> worin R¹ und R² gleich oder verschieden sind und Chlor-, Brom- oder Fluoratome oder Methyl-, Ethyl-, Methoxy-, Trifluormethyl - oder Cyangruppen darstellen, R³ die für R¹ bzw. R² angegebene Bedeutung hat oder ein Wasserstoffatom ist und Ar einen gegebenenfalls substituierten mono- oder bicyclischen heteroaromatischen Rest mit 1 bis 3 Stickstoff- und/oder Sauerstoff- und/oder Schwefelstomen darstellt, sowie deren Salze mit physiologisch verträglichen Säuren, deren Herstellung und diese enthaltende Arzneimittel. Die Verbindungen besitzen u.a. blutdrucksenkende Wirkung. The invention relates to 1-aroyl-2-phenylamino-2-imidazolines of the general formula <IMAGE> in which R¹ and R² are identical or different and chlorine, bromine or fluorine atoms or methyl, ethyl, methoxy, trifluoromethyl or cyano groups represent, R³ has the meaning given for R¹ or R² or is a hydrogen atom and Ar represents an optionally substituted mono- or bicyclic heteroaromatic radical having 1 to 3 nitrogen and / or oxygen and / or sulfur atoms, and their salts with physiologically compatible Acids, their preparation and medicinal products containing them. The connections include hypotensive effect.

Inter-block data management

An exemplary embodiment of the present invention may divide data into a first of set of blocks and a second set of blocks, and data may be stored from non-overlapping frames surrounding the first set of blocks in memory. The data may be grouped from the non-overlapping frames surrounding the second set of blocks, and the data may be absorbed from the non-overlapping frames surrounding the first set of blocks into the second set of blocks. The data may be processed the first set of blocks and the second set of blocks in parallel.

Patent GR70672B

PROCESS FOR PREPARING PHENYL N-METHYLCARBAMINIC ACID ESTERS WITH INSECTICIDE ACTIVITY AND PREPARATIONS CONTAINING THESE COMPOUNDS.

QUINOLINE-THIONO-PHOSPHONE-ACID ESTER, METHOD FOR THEIR PRODUCTION AND USE AS INSECTICIDES AND ACARICIDES

Universal compatible pigment dispersants

IODPHENYL (THIONO) -PHOSPHORUS (PHOSPHONE) ACID ESTERS, -ESTERAMIDES AND -ESTERDIAMIDE, METHOD FOR THEIR PRODUCTION AND THEIR USE AS INSECTICIDES AND ACARICIDES

Implantable fluid delivery apparatuses and implantable electrode

Implantable fluid delivery systems and implantable electrodes (203) are provided. The fluid delivery systems may include an implantable fluid source (113), a first catheter (109) in fluid communication with the implantable fluid source, and an implantable micro-valve (101) in fluid communication with the first catheter. The electrodes include a front end (2007) and back end (2005) for ease of implantation. One or more of the electrodes may be combined with a fluid delivery system to provide fluid to the body of a subject.

Inter-block data management

An exemplary embodiment of the present invention may divide data into a first of set of blocks and a second set of blocks, and data may be stored from non-overlapping frames surrounding the first set of blocks in memory. The data may be grouped from the non-overlapping frames surrounding the second set of blocks, and the data may be absorbed from the non-overlapping frames surrounding the first set of blocks into the second set of blocks. The data may be processed the first set of blocks and the second set of blocks in parallel.

Implantable Fluid Delivery Apparatuses and Implantable Electrode

An electrode for an implantable prosthesis includes a flexible front end including one or more metal contacts and a back end including one or more metal contacts. The electrode has a cross-sectional shape along the electrode, and the cross-sectional shape has a discontinuity between the flexible front end and the back end. The cross-sectional shape does not have a substantially constant diameter and does not have a continuously growing diameter. The cross-sectional shape of the flexible front end is substantially smaller than the cross-sectional shape of the back end such that forces required to bend the flexible front end are less than forces required to bend the back end.

O-PHENYLTHIONOPHOSPHONIC ACID ESTERS, METHOD FOR THEIR MANUFACTURING AND USE AS INSECTICIDES, ACARICIDES AND NEMATICIDES

Device and method for implants in ossified cochleas

A hearing prosthesis for implantation into a subject's ossified cochlea, is provided that includes a plurality of electrode carriers associated with a single receiver/stimulator, and a plurality of discrete shaped contact member pairs arranged at a predetermined spacing along a fraction of the length of each electrode carrier, wherein each contact member pair is superficially placed on the carrier and comprises a first contact member diametrically opposed to a second contact member.

N,n-dimethyl-o-pyrimidinyl-carbamic acid esters, process for their preparation and their use as pesticides

N, N-DIMETHYL-N 'SQUARE BRACKET ON 0-PHENYL (THIONO) -ALKANE PHOSPHONYL SQUARE BRACKET TO FORMAMIDINE, METHOD FOR THEIR PRODUCTION AND USE AS INSECTICIDES, ACARICIDES AND NEMATICIDES

Composition comprising a pulmonary surfactant and a tnf-derived peptide

The invention relates to the combination of a pulmonary surfactant and a TNF-derived peptide and its use for the treatment of respiratory disease.

1-Benzoyl-3-(4-phenoxyphenyl)ureas - with insecticidal activity and low mammalian and plant toxicity

Novel 1-benzoyl-3-(4-phenoxyphenyl) ureas of formula (I) (where R1 is F, Cl, Br or Me; R2 is H, F or Cl; R3 is H or Cl; R4 is H, Cl or Me; R5 is H or Cl, R2 is NO2 or CF3) are insecticides with low mammalian and plant toxicity. A concn. of 0.001% applied to Plutella maculipennis gives a destruction of 90-100% after 8 days.

Hydroxamic-acid esters, process for their manufacture, their use in pesticides and intermediate products therefor

Hydroxamic acid esters of the formula <IMAGE> in which R1 is an optionally substituted alkyl, cycloalkyl, aryl or aralkyl radical and R2 is an alkyl, alkenyl or alkinyl radical, or R1 and R2 together are an alkylene bridge with 2 to 4 carbon atoms, one of the radicals R3 and R4 is <IMAGE> while the other is an alkyl, alkenyl, alkinyl, halogenoalkenyl or alkoxyalkyl radical, and X is O or S, which possess pesticidal properties. Intermediates therefor wherein one of N-OR3 and N-OR4 is N-OH or a carbonyl group are also new.

N-arylalkyl-phenylalkyl amines

Implantable fluid delivery apparatuses and implantable electrode

Implantable fluid delivery systems and implantable electrodes (203) are provided. The fluid delivery systems may include an implantable fluid source (113), a first catheter (109) in fluid communication with the implantable fluid source, and an implantable micro-valve (101) in fluid communication with the first catheter. The electrodes include a front end (2007) and back end (2005) for ease of implantation. One or more of the electrodes may be combined with a fluid delivery system to provide fluid to the body of a subject.

S- (TRIFLUORCHLORAETHYLMERCAPTO) - AETHYL (THIONO) - (DI) THIOLPHOSPHORUS (PHOSPHONE) - ACID ESTER OR. -ESTERAMIDE, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS INSECTICIDE, ACARICIDE AND NEMATICIDE

SYSTEM IMPLEMENTED WITH CONTINUOUS CURRENT FREE INPUTS AND OUTPUTS

Se describe un sistema electronico implantable. Una fuente de alimentacion implantable incluye multiples puertos de entrada de alimentacion para recibir una senal de alimentacion de potencia generada externamente, y multiples puertos de salida de potencia para desarrollar una senal de potencia detectada. Un modulo de procesamiento prostético implantable incluye multiples puertos de entrada de procesamiento prostético conectados por cable a los puertos de salida de potencia para recibir la senal de potencia detectada, y multiples puertos de salida de procesamiento prostético para desarrollar una senal de estimulacion prostética a fin de estimular eléctricamente el tejido neural blanco. Cada uno de los multiples puertos está adaptado para operar sin desarrollar un potencial de cc. An implantable electronic system is described. An implantable power supply includes multiple power input ports to receive an externally generated power supply signal, and multiple power output ports to develop a detected power signal. An implantable prosthetic processing module includes multiple prosthetic processing input ports connected by cable to the power output ports to receive the detected power signal, and multiple prosthetic processing output ports to develop a prosthetic stimulation signal in order to Electrically stimulate white neural tissue. Each of the multiple ports is adapted to operate without developing a DC potential.

Method for determining the distance of an object moving relative to a camera arrangement

Verfahren zur Abstandsbestimmung eines sich relativ zu einer Kameraanordnung bewegenden Objektes mit folgenden Verfahrensschritten: a. Erzeugung eines Bildobjekts o in einer Bildebene E einer Kameraanordnung K mit einer Brennweite f b. Bestimmung einer Bildgeschwindigkeit v des Bildobjekts o in der Bildebene E c. Bestimmung einer Relativgeschwindigkeit V zwischen Kameraanordnung K und Objekt O d. Bestimmung eines Richtungswinkels α zwischen einer optischen Achse A der Kameraanordnung K und einem Objektrichtungsvektor O→ , e. Bestimmung eines Abstandswertes R des Objekts O aus der Relativgeschwindigkeit V, der Bildgeschwindigkeit v, der Brennweites f und dem Richtungswinkel α. Method for determining the distance of an object moving relative to a camera arrangement with the following method steps: a. Generation of an image object o in an image plane E of a camera arrangement K with a focal length f b. Determination of an image speed v of the image object o in the image plane E c. Determination of a relative speed V between camera arrangement K and object O d. Determination of a direction angle α between an optical axis A of the camera arrangement K and an object direction vector O →, e. Determination of a distance value R of the object O from the relative speed V, the image speed v, the focal length f and the directional angle α.

0,0-DIAETHYL-0-SQUARE CLIP ON N-METHOXY-2-NITROBENZIMIDOYL SQUARE CLIP ON-THIONOPHOSPHORIC ACID, METHOD FOR ITS MANUFACTURING AND ITS USE AS INSECTICIDE AND ACARICIDE

QUATERNAERE ALKYLAMINO-DI-ALKYLCARBONÄSURE-DI-ESTER, METHOD FOR THE PRODUCTION AND USE THEREOF

FLUORALKENYL-SUBSTITUTED CYCLOPROPANCARBONIC ACID ESTERS AND THEIR USE AS INSECTICIDES

2,2-Dimethyl-3-(2'-perfluoroalkyl-2'-perhaloalkyl-vinyl)-cyclopropane of the formula <IMAGE> in which R is -COOR2, -COOH, -CO-Halogen, -CN or -CO-CH3, R1 is fluorine or CF3, R3 is fluorine, chlorine, bromine or R1CF2-, and R2 is the radical of an alcohol which possess arthropodicidal properties. These compounds can be produced by adding a compound of the formula <IMAGE> to an olefin of the formula <IMAGE> to produce a compound of the formula <IMAGE> and dehydrohalogenating said compound. This compound may be hydrolyzed, saponified or esterified, depending upon the particular derivative desired.

2-arylamino-3,5-dinitro-benzotrifluorides, process for their preparation and their use as pesticides.

0-TRIAZOLYL- (THIONO) -PHOSPHORUS (PHOSPHONE, PHOSPHINE) -AEUREESTER OR. -ESTERAMIDE, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS INSECTICIDE, ACARICIDE AND NEMATICIDE

1-Benzoyl-3-(4-phenoxyphenyl)ureas - with insecticidal activity and low mammalian and plant toxicity

Novel 1-benzoyl-3-(4-phenoxyphenyl) ureas of formula (I) (where R1 is F, Cl, Br or Me; R2 is H, F or Cl; R3 is H or Cl; R4 is H, Cl or Me; R5 is H or Cl, R2 is NO2 or CF3) are insecticides with low mammalian and plant toxicity. A concn. of 0.001% applied to Plutella maculipennis gives a destruction of 90-100% after 8 days.

Novel n-sulphenylated carbamates and their use as insecticides and acaricides

N-methyl-N-(benzene sulfonic acid methylamide-N'-sulfenyl)-carbamic acid esters of the formula IN WHICH X is halogen, C1-C6 alkyl or hydrogen, and R is a phenyl, naphthyl, benzodioxolanyl or indanyl radical optionally carrying at least one alkyl, alkenyl, alkynyl, alkoxy, alkenoxy, alkynoxy, alkylmercapto, alkenylmercapto, alkynylmercapto, dialkylamino, trihalogenomethyl, halogeno, nitro, nitrile, cycloalkyl, formamidino, dioxanyl or dioxolanyl radical; or an oxime radical of the formula R1 -N=C ANGLE (II) R2 in which R1 and R2 each individually is alkyl, alkoxy, alkylthio or alkoxycarbonyl, the alkyl moieties of R1 and R2 optionally being linked to one another, WHICH POSSESS INSECTICIDAL AND ACARICIDAL PROPERTIES. [US3954836A]

Patent GR69346B

Washing materials containing softening agent

Softener-containing washing agents which, in addition to the customary components of washing agents, contain 0 to 10% by weight of a quaternary ammonium compound and 1 to 30% by weight of a softener system which comprises 10 to 90% by weight of a tertiary amine and 90 to 10% by weight of a crystalline sheet-silicate of the formula Me2SixO2x+1x yH2O in which Me denotes an alkali metal ion or a proton, x denotes a number greater than 7, in particular from 7.5 to 23, and y denotes a number smaller than 7 x, in particular smaller than x. In the softener system, the tertiary amine is in a state of adsorption on the alkali metal silicate. The ammonium compounds, which are adsorbed on said silicate, produce a softening effect in the washing agent but on the other hand are compatible with anionic surfactants in the washing agent. produce a softening effect in the washing agent but on the other hand are compatible with anionic surfactants in the washing agent.

Automatic image enhancement

Ein Verfahren zur automatischen Bildverbesserung, das folgende Schritte umfasst: Empfangen eines digitalen Bildes (200); Extrahieren einer Mehrzahl von Attributmessungen (202) von dem digitalen Bild (200); Erzeugen von zumindest einem Rauschschwellenwertparameter (606), einem Schärfeparameter (608) und einem Radikalitätsparameter (610) basierend auf den extrahierten Attributmessungen (202, 604); Bewerten des Rauschschwellenwertparameters basierend auf zumindest einer Attributmessung (612), um den Rauschreduktionsgrad zu definieren, der durchzuführen ist; Bewerten des Schärfeparameters basierend auf zumindest einer Attributmessung (614), um den Schärfungsgrad zu definieren, der durchzuführen ist, wobei der Rauschreduktionsgrad und der Schärfungsgrad zusammen eine bestimmte Verbesserung (204) für das digitale Bild (200) darstellen; Bewerten des Radikalitätsparameters basierend auf zumindest einer Attributmessung (212, 616), um die Radikalität der bestimmten Verbesserung zu definieren, die durchzuführen ist; und Durchführen (632), bezüglich der Radikalität der bestimmten Verbesserung, eines Prozentsatzes des bestimmten Rauschreduktionsgrads und eines Prozentsatzes des bestimmten Schärfungsgrads an dem empfangenen digitalen Bild... An automatic image enhancement method comprising the steps of: Receiving a digital image (200); Extracting a plurality of attribute measurements (202) from the digital image (200); Generating at least one noise threshold parameter (606), a sharpening parameter (608), and a radicality parameter (610) based on the extracted attribute measurements (202, 604); Evaluating the noise threshold parameter based on at least one attribute measurement (612) to define the noise reduction level to be performed; Evaluating the sharpening parameter based on at least one attribute measurement (614) to define the degree of sharpening to be performed, the noise reduction level and the sharpening level together representing a particular enhancement (204) to the ...

0-PYRAZOLOPYRIMIDINE (THIONO) PHOSPHORUS (PHOSPHONE) ACID ESTER, METHOD FOR THEIR PRODUCTION AND USE AS INSECTICIDES AND ACARICIDES

Respirator mask with inner half mask and pollutant indicator

Cochlear implant system partially insertable in the external ear

A cochlear implant system has a signal processor (50) that fits in the ear canal of a user. The signal processor (50) processes an acoustic signal present in the ear of the user to produce a representative radio signal. A power transmitter transmits an electrical power signal through the skin of the user. A cochlear implant receives the radio signal and the electrical power signal and produces for the auditory nerve of the user an electrical stimulation signal representative of the acoustic signal.

2 ', 3,6'-TRICHLORO-4-CYANO-4'-BENZOYLUREIDO-DIPHENYL ETHER, METHOD FOR THEIR PREPARATION AND USE AS INSECTICIDES

PHENYLCARBAMOYL PYRAZOLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INSECTICIDES

N,n-dimethyl-o-pyrazolyl esters of carbamic acid, process for their preparation and their use as pesticides

Acetyl-subst o-vinyl-(thiono)phosph(on)ates - with insecticidal and acaricidal activity

Title compounds of formula (I) (where R is 1-6C alkyl or alkoxy; R' and R"' are 1-6C alkyl; R" is H or CH3; and X is O or S9 are prepared by (a) reacting a compound (R'O) (R)PX-HAL (where Hal is halogen) with CH2COCH (SR"')COCH3 in the presence of an acid binding agent (gives (I; R"'=CH3)), (b) reacting CH3COCH2SR"' with HCOOC2H5 in the presence of an alcoholate and reacting the resulting CH3COC(SR"')=CH-OM (where M is a monovalent, pref. an alkali metal atom) with (R'O) (R)PX-Hal (gives (I.R"=H)) or (c) halogenating CH3COCH(SR"')- COCH3 to give (CH3CO)2C to give (CH3CO)2C(Hal)SR"' and reacting this with P(OR')3 (gives (I; R=OR', R"= CH3)).

Implanted system with DC free inputs and outputs

Three-dimensional printing

A three-dimensional printing method can include iteratively applying polymer build material as individual layers; based on a three-dimensional object model, selectively jetting an electromagnetic radiation absorber and a translucency-modulating plasticizer onto individual layers of the polymer build material; and exposing the powder bed to electromagnetic energy to selectively fuse portions of individual layers of the polymer build material together to form a three-dimensional object. The polymer build material can include from about 60 wt % to 100 wt % polymeric particles having an average particle size from about 10 ?m to about 150 ?m and a degree of crystallinity from about 2% to about 60%, to a powder bed. At the locations where the polymer build material includes jetted translucency-modulating plasticizer, the three-dimensional object can exhibit an optical transmittance from about 5% to about 80%.

Universally compatible pigment dispersants

SOFT SOFTENER

Fabric softeners which result in an improved rewettability of the textile material treated with the same and which are present in the form of an aqueous solution or dispersion containing from 3 to 15% by weight of one or several quaternary ammonium compounds and from 0.5 to 1.5% by weight of a compound of the formula <IMAGE> in which R4 is alkyl or alkenyl of from 4 to 20 carbon atoms, cyclohexyl or aryl optionally substituted by alkyl groups, x and y are hydrogen or methyl, but are not methyl at the same time, n is a number of from 0 to 20, Z is a group of formula -(CH2)mCOOMe, -SO3Me or -PO3Me2+L, m is an integer of from 0 to 3, and Me is an alkali metal or ammonium ion, as well as optionally further common auxiliaries and additives.

Implant sensor and control

Abstract An implant includes a humidity sensor for generating a signal indicative of humidity within the implant. A controller within the implant receives the signal indicative of humidity, and controls the implant based on the signal indicative of humidity. 2776075_1 (GHMatters) P81661.AU.I Humidity Sensor Stimulator Controller

0-PHENYL-N-ALKOXY- (THIONO) -PHOSPHORUS (PHOSPHONE) -ACID ESTERAMIDE, METHOD FOR THEIR PRODUCTION AND USE AS INSECTICIDES AND ACARICIDES

Carboxylmethyl%di

Opacifying agent application in three-dimensional printing

A three-dimensional printing system includes a controller to instruct a fusing agent distributor to selectively apply a fusing agent to a first region of a layer of build material. The controller also determines a subset of voxels in the layer of build material to provide an opacifying agent based on an opacity value of an opacified region of an object to be generated and instructs an opacifying agent distributor to apply the opacifying agent to the determined subset of voxels.

A process for the preparation of therapeutically useful chromium derivatives

DIPHOSPHORYLATED PYRIMIDINS, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS INSECTICIDES AND ACARICIDES

Process for the preparation of thiazolo (thiono) phosphorus (phosphonic) acid esters

INSECTICIDAL AND ACARICIDAL AGENT.